Page 1668 - Clinical Small Animal Internal Medicine
P. 1668

1606  Index

                                                                                 stomach  486–487, 486–487
            fluid therapy (cont’d)           focal/localized intrathoracic airway   FOS see fat overload syndrome
  VetBooks.ir  crystalloid fluids  358–359   focal/multifocal parenchymal      fPL see feline pancreatic lipase
                                                 narrowing/collapse  383
              constant rate infusions  363
              critical care setting  347–349
                                                                               FPV see feline parvovirus
                                                 disease  666–667
              dehydration  361–362, 364      focused assessment with sonography   fractures  1518–1519
              ehrlichiosis and anaplasmosis  911  for trauma (FAST)            fragmented medial coronoid process
              end‐of‐life care  1559           pleural effusion  336               (FMCP)  1542–1544
              feline inflammatory liver        shock  406                      Francisella tularensis see tularemia
                disease  690                   surgical, traumatic, and bite wound   Frank–Starling curves  181–183, 181
              feline viral upper respiratory tract   infections  1033          FRD see food‐responsive diarrhea
                disease  888                   trauma and burns  449           free water deficit  362
              fever  434–435                 FOD see fibrous osteodystrophy    friability  512–513, 513, 521–522, 526
              glomerular disease  1106       follicle‐stimulating hormone      FSA see fibrosarcoma
              head trauma  755                   (FSH)  29, 36–38              FSH see follicle‐stimulating hormone
              heat stroke  435–436           follicular casts  1387, 1496      functional ileus  497
              hypothermia  432–433           food‐responsive diarrhea (FRD)     functional urethral obstruction
              indications for fluid              627–629, 634–637                  1186–1187
                therapy  360–363             foramenal herniation  750         fungal infections  985–1001
              intravenous fluid types  358–360  forebrain disorders  773–788     antifungal therapy  1049–1053
              maintenance fluids  362          anatomy/function  773             approach to the dermatologic
              metabolic diseases  680          anomalous causes  775–776           patient  1393
              monitoring of fluid              cerebrovascular accidents  785–787  cutaneous manifestations of systemic
                therapy  363–364               clinical signs  774                 disease  1485, 1485
              motility disorders  577–579      degenerative and developmental    diagnosis  985–986
              pancreatitis  597, 606             causes  775                     epidemiology and signalment  985
              rapid volume expansion  360–361  differential diagnosis  774       etiology/pathophysiology  985
              septic shock  426                electrolyte disturbances  777–778  history and clinical signs  985
              shock  409–410                   etiology/pathophysiology  773, 774  laboratory diagnosis  845–847, 846
              spotted fever and typhus group   feline ischemic                   miscellaneous fungus‐like
                Rickettsia  939–940              encephalopathy  787–788           infections  999–1000
              surgical approaches to thoracic   hepatic and uremic               principles of therapy of dermatologic
                disease  328–329                 encephalopathy  776–777           diseases  1401
              synthetic colloids  359–360      hydrocephalus  775–776, 776       public health implications  987
              trauma and burns  450–451, 453   infectious diseases  781–784      treatment and prognosis  986–987
              urethral obstruction  1111–1112  inflammatory/idiopathic           see also individual agents/diseases
              vascular access  355–356           causes  780–784               furunculitis/furunculosis  1451–1452,
              water movement  357–358          L2‐hydroxyglutaric aciduria         1452, 1465
            fluorescence in situ hybridization   775, 775
                (FISH)  960                    metabolic causes  776–778       g
            fluoroquinolones  310, 924,        neoplastic causes  778–780      gag reflex  739
                1045–1046                      nutritional causes  780         gait and posture
            fluoroscopy                        storage diseases  775             myelopathy  817–818
              canine chronic bronchitis        vascular causes  785–788          neurologic assessment  731–732
                306–307                      foreign bodies                      osteoarthritis  1531
              congenital heart disease         endoscopy  516, 519, 529–530, 530  gallbladder  721–726
                243, 243                       esophagus  476–477, 477–478, 558,   diagnosis  723–725
              hepatobiliary disease  672, 672    560–562                         epidemiology  722
              motility disorders  566, 572     fluid therapy  356                etiology/pathophysiology
              ureteral obstruction  1120–1121,   large intestine  502–504, 503     721–722, 722
                1121                           linear foreign bodies  494, 494   hepatobiliary disease  669–670, 670
            FMCP see fragmented medial coronoid   motility disorders  571        history and clinical signs  722–723
                process                        oral cavity and salivary glands  542  liver disease  651–652
            FNA see fine needle aspiration     rectoanal diseases  615–616       prognosis  726
            focal ischemic alopecia  1433      small intestine  493–494, 494     signalment  722
   1663   1664   1665   1666   1667   1668   1669   1670   1671   1672   1673